ОПИОИДНЫЕ РЕЦЕПТОРЫ: ВОЗМОЖНОСТИ И ПЕРСПЕКТИВЫ
https://doi.org/10.17021/2020.15.3.16.23
Аннотация
Об авторах
М. И. ДмитриевскаяРоссия
Е. В. Середа
Россия
Список литературы
1. Abbott, N. J. Structure and function of the blood-brain barrier / N. J. Abbott, A. A. K. Patabendige, D. E. M. Dolman, S. R. Yusof, D. J. Begley // Neurobiology of Disease. - 2010. - Vol. 37. - P. 13-25.
2. Allouche, S. Opioid receptor desensitization : mechanisms and its link to tolerance / S. Allouche, F. Noble, N. Marie // Front Pharmacol. - 2014. - Vol. 5. - P. 280-283.
3. Campbell, A. W. The blood-brain barrier / A. W. Campbell // Altern. Ther. - 2016. - Vol. 22. - P. 6-7.
4. Chaves, C. Effect of subchronic intravenous morphine infusion and naloxone-precipitated morphine with- drawal on P-gp and Bcrp at the rat blood-brain barrier / C. Chaves, D. Gomez-Zepeda, S. Auvity, M.-C. Menet, D. Crete, L. Labat, F. Remião, S. Cisternino, X. Declèves // J. Pharm. Sci. - 2015. - Vol. 105, № 1. - P. 350-358.
5. Chavkin, C. The therapeutic potential of kappa-opioids for treatment of pain and addiction / C. Chavkin // Neuropsychopharmacology. - 2011. - Vol. 36. - P. 369-370.
6. Chen, X. T. Structure-activity relationships and discovery of a G protein biased µ opioid receptor ligand, [(3-methoxythiophen-2-yl)methyl]({2-[(9R)-9-(pyridin-2-yl)-6-oxaspiro-[4.5]de can-9-yl]ethyl})amine (TRV130), for the treatment of acute severe pain / X. T. Chen, P. Pitis, G. Liu, C. Yuan, D. Gotchev, C. L. Cowan, D. H. Rominger, M. Koblish, S. M. Dewire, A. L. Crombie, J. D. Violin, D. S. Yamashita // J. Med. Chem. - 2013. - Vol. 56. - P. 8019-8031.
7. Christopoulos, A. Advances in G protein-coupled receptor allostery : from function to structure / A. Christopoulos // Molecular pharmacology. - 2014. - Vol. 86. - P. 463-478.
8. DeWire, S. M. A G protein-biased ligand at the mu-opioid receptor is potently analgesic with reduced gastrointestinal and respiratory dysfunction compared with morphine / S. M. DeWire, D. S. Yamashita, D. H. Rominger, G. Liu, C. L. Cowan, T. M. Graczyk, X. T. Chen, P. M. Pitis, D. Gotchev, C. Yuan, M. Koblish, M. W. Lark, J. D. Violin // J. Pharmacol. Exp. Ther. - 2013. - Vol. 344. - P. 708-717.
9. Eddy, M. T. Allosteric Coupling of Drug Binding and Intracellular Signaling in the A(2A) Adenosine Receptor / M. T. Eddy, M. Y. Lee, Z. G. Gao, K. L. White, T. Didenko, R. Horst // Cell. - 2018. - Vol. 17. - P. 21-22.
10. Fanelli, G. Developments in managing severe chronic pain : role of oxycodone-naloxone extended release / G. Fanelli, A. Fanelli // Drug. Des. Devel. Ther. - 2015. - Vol. 9. - P. 3811-3816.
11. Fenalti, G. Molecular control of delta-opioid receptor signaling / G. Fenalti, P. M. Giguere, V. Katritch, X. P. Huang, A. A. Thompson, V. Cherezov, B. L. Roth, R. C. Stevens // Nature. - 2014. - Vol. 506. - P. 191-196.
12. Fenalti, G. A novel approach to quantify G-protein-coupled receptor dimerization equilibrium using bioluminescence resonance energy transfer / G. Fenalti, I. Kufareva, B. Stephens, C. T. Gilliland // Methods Mol. Biol. - 2013. - Vol. 1013. - P. 93-127.
13. Fenalti, G. Structural basis for bifunctional peptide recognition at human delta-opioid receptor / G. Fenalti, N. A Zatsepin, C. Betti, P. Giguere, G. W. Han, A. Ishchenko, V. Cherezov // Nature Structural & Molecular Biology. - 2015. - Vol. 22, № 3. - P. 265-268.
14. Ferre, S. G protein-coupled receptor oligomerization revisited : functional and pharmacological perspectives : S. Ferre, V. Casado, L. A. Devi, M. Filizola, R. Jockers, M. J. Lohse, G. Milligan, J. P. Pin, X. Guitart // Pharmacological reviews. - 2014. - Vol. 66. - P. 413-434.
15. Fossepre, M. On the Modularity of the Intrinsic Flexibility of the micro Opioid Receptor : A Computational Study / M. Fossepre, L. Leherte, A. Laaksonen, D. P. Vercauteren // PloS one. - 2014. - Vol. 9. - P. 115-121.
16. Kliewer, A. Emerging paradigms of G protein-coupled receptor dephosphorylation / A. Kliewer, R. K. Reinscheid, S. Schulz // Trends Pharmacol. Sci. - 2017. - Vol. 38. - P. 621-636.
17. Madariaga-Mazón, A. Mu-Opioid receptor biased ligands : a safer and painless discovery of analgesics? / A. Madariaga-Mazón, A. F. Marmolejo-Valencia, Y. Li, L. Toll, R. A. Houghten, K. Martinez-Mayorga // Drug. Discov. Today. - 2017. - Vol. 22. - P. 1719-1729.
18. Mahringer, A. The blood - brain barrier : An Introduction to its structure and function / A. Mahringer, M. Ott, G. Fricker // The blood brain barrier (BBB) / Ed.G. Fricker, M. Ott, A. Mahringer. - Heidelberg: Springer, Topics in Medicinal Chemistry, 10. - 2014. - P. 1-20.
19. Manglik, A. Structure-based discovery of opioid analgesics with reduced side effects / A. Manglik, H. Lin, B. K. Shoichet // Nature. - 2016. - Vol. 537. - P. 185-190.
20. Martinez-Mayorga, K. Ligand/kappa-opioid receptor interactions : insights from the X-ray crystal structure / K. Martinez-Mayorga, K. G. Byler, A. B. Yongye, M. A. Giulianotti, C. T. Dooley, R. A. Houghten // European Journal Of Medicinal Chemistry. - 2013. - Vol. 66. - P. 114-121.
21. Pasternak, G. W. Identification of novel high affinity opiate receptor binding in rat brain / G. W. Pasternak, S. H. Snyder // Nature. - 1975. - Vol. 253. - P. 563-565.
22. Schinkel, A. H. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs / A. H. Schinkel, J. J. M. Smit, O. van Tellingen, J. H. Beijnen, E. Wagenaar, L. Deemter, P. Borst // Cell. - 1994. - Vol. 77. - P. 491-502.
23. Soergel, D. G. Biased agonism of the μ-opioid receptor by TRV130 increases analgesia and reduces on-target adverse effects versus morphine : A randomized, double-blind, placebo-controlled, crossover study in healthy volunteers / D. G. Soergel, R. A. Subach, N. Burnham, M. W. Lark, I. E. James, B. M. Sadler, F. Skobieranda, J. D. Violin, L. R. Webster // Pain. - 2014. - Vol. 155, № 9. - P. 1829-1835.
24. Srivastava, A. High-resolution structure of the human GPR40 receptor bound to allosteric agonist TAK-875 / A. Srivastava, J. Yano, Y. Hirozane, G. Kefala, F. Gruswitz, G. Snell, W. Lane, A. Ivetac, K. Aertgeerts, J. Nguyen, A. Jennings, K. Okada // Nature. - 2014. - Vol. 513. - P. 124-127.
25. Thompson, G. L. Novel GPCR paradigms at the mu-opioid receptor : G. L. Thompson, E. Kelly, A. Christopoulos, M. Canals // British J. of Pharmacology. - 2015. - Vol. 172. - P. 287-296.
26. Violin, J. D. Biased ligands at G-protein-coupled receptors : promise and progress / J. D. Violin, A. L. Crombie, D. G. Soergel, M. W. Lark // Trends in pharmacological sciences. - 2014. - Vol. 35, № 7. - P. 308-316.
27. Viscusi, E. Rapid reduction in pain intensity with oliceridine (TRV130), a novel µ receptor G protein path- way selective modulator (µ-GPS), vs. morphine : an analysis of two phase 2 randomized clinical trials / E. Viscusi, H. Minkowitz, L. Webster, D. Soergel, D. Burt, R. Subach, F. Skobieranda // Pain. - 2016. - Vol. 17, № 4. - P. 582-583.
28. White, K. L. Identification of novel functionally selective kappa-opioid receptor scaffolds / K. L. White, A. P. Scopton, M. L. Rives, R. V. Bikbulatov, P. R. Polepally, P. J. Brown, T. Kenakin, J. A. Javitch, J. K. Zjawiony, B. L. Roth // Molecular pharmacology. - 2014. - Vol. 85. - P. 83-90.
Рецензия
Для цитирования:
Дмитриевская М.И., Середа Е.В. ОПИОИДНЫЕ РЕЦЕПТОРЫ: ВОЗМОЖНОСТИ И ПЕРСПЕКТИВЫ. Астраханский медицинский журнал. 2020;15(3):16-23. https://doi.org/10.17021/2020.15.3.16.23
For citation:
Dmitrievskaya M.I., Sereda E.V. OPIOID RECEPTORS: OPPORTUNITIES AND PROSPECTS. Astrakhan medical journal. 2020;15(3):16-23. (In Russ.) https://doi.org/10.17021/2020.15.3.16.23